Differences in evidentiary requirements for oncology drug effectiveness assessments among six European Health technology assessment bodies - can alignment be improved?

Alignment can be enhanced to reduce time to decision-making and to improve equity in patient access. Proposed recommendations to achieve this included joint early dialogs, intensified collaboration and exchange between countries, joint relative effectiveness assessments, and the use of access agreements.